What effect did the dramatic expansion in long distance trade in the early modern period have on healthcare in England? This paper presents new evidence on the scale, origins and content of English imports of medical drugs between 1567 and 1774. It shows that the volume of medical drugs imported exploded in the seventeenth century, and continued growing more gradually over the eighteenth century. The variety of drugs imported changed more slowly. Much was re-exported, but estimates of dosages suggest that some common drugs (e.g.: senna, Jesuits' bark) were available to the majority of the population in the eighteenth century. English demand for foreign drugs provides further evidence for a radical expansion in medical consumption in the seventeenth century. It also suggests that much of this new demand was met by purchasing drugs rather than buying services.
surprising given the importance of imported goods such as sugar, tea, tobacco, and calicos to analyses of consumption more generally, and the growing interest in perceptions of exotic drugs and their impact on natural philosophy. 4 In this paper, I present new evidence on the trajectory of the English medical drug trade between 1567 and 1774 showing that consumption of imported medical drugs exploded in the seventeenth century and continued growing more gradually over the eighteenth century. Medicines flooded in alongside other commodities as England moved from being the last step on a long supply chain that crossed Europe and the Levant to a major entrepôt for the rest of the continent.
This account of medical drugs has relevance to general histories of consumption: by considering the full range of old and new medical drugs imported it allows an insight into the significance of novelties in inspiring consumption, and by covering a longer period than most studies it permits longer run trends to be identified. More specifically, understanding the dramatic changes in the volume and type of drugs that were imported between the sixteenth and eighteenth centuries allows us to engage with two central issues in the history of early modern medicine. The first is the timing and scale of the shift in English demand for commercially-supplied healthcare. The second is whether the very significant theoretical changes in medicine in this period were reflected in what people used as drugs: or how quickly, and how extensively, was the character of medicine changing?
The availability of imported drugs offers a distinctive measure of healthcare consumption. Most studies to date have focussed on the personnel supplying healthcare rather than the materials involved, exploring the density of practitioners, the activities of particular individuals and groups of medical practitioners, and, more recently, the frequency of resort to practitioners among the seriously ill.
5 By developing this last method, Ian Mortimer has quantified levels of demand for medical services in Southern England over the seventeenth century, concluding that an increase of between 400 and 1,000 percent occurred from 1620 to 1690. 6 Examining drug imports allow us to extend and contextualize
Mortimer's analysis: drug imports suggest whether his account of responses to serious illness extends to a wider variety of conditions; they show how the trajectory of consumption developed over the century after his study ends; and they reveal national, rather than regional, patterns. By examining the types of drugs imported, we can also explore one of the main explanatory hypotheses Mortimer put forwards for the increase in consumption that he observed: a shift in the type of medicine used from Galenic to chemical or Paracelsian medicine.
7
The volume and price of imported drugs is, of course, only an indirect measure of the degree to which the population was utilising a particular kind of healthcare. Medicine also made much use of homegrown drugs and other substances, various plants were domesticated in English physic gardens in this period, substitutes for imported drugs were available, and medicines were only one part of the art of physic, alongside diet, exercise and other non-naturals. 8 Some practitioners appear to have used remedies in only a minority of cases. 9 Nonetheless, foreign drugs were an important part of the therapeutic core of much commercial medicine, particularly in Galenic physic. They were also central to the retail trade in medical substances; they were the mainstay of the remedies sold in the shops of apothecaries, druggists, and other retailers. 10 For a medicine established and fostered around the shores of the Mediterranean, the heartland of the pharmacopoeia inevitably lay far to the south of England's shores. If imports of medical drugs were not arriving in large quantities, then we can reasonably presume that this form of medicine was not being used widely, and vice versa.
Sources and Method
English drug imports and exports are recorded in two main locations: for the sixteenth and seventeenth centuries, Port Books contain undifferentiated lists of the cargoes of ships which were noted down as they entered and left the country; from 1696, overseas trade is summarised in the annual ledgers of the Inspector-General of the Customs. These records were kept as part of the process by which customs' duties were collected. Because of this, both the Port Books and the Ledgers have a number of limitations. Goods imported or exported duty-free were not recorded. 11 The estimates of value they contain were based on dubious prices and calculations. Incorrect entries at the customs house are also an issue: false entries are a feature of the system, particularly for geographical information, where monopolies of colonial trade supplied motives for lying about origins and destinations of goods. 12 More importantly, drugs may have been smuggled to avoid tax, despite its relatively low rate for the early part of the period.
13
Port Books and Ledgers also present particular practical challenges. First, Port Book survival is geographically patchy.
14 10 Wallis 2002 , pp. 194-8. 11 Willan 1962 , p. x. 12 Clark 1938 Hoon 1937, p. 257; Ashworth 2003, pp.133--64 . 13 Ashworth 2003, pp. 165-83. 14 Several Port Books used by Roberts are no longer fit for production.
Fortunately, survival appears to be best for London, the epicentre of the drug trade. I take London's records as a proxy for national import totals For the data before 1699, all individual drug consignments that were substantial enough to affect the total for a year (making up >5% of the annual total by value) were rechecked, as were any imports that differed markedly from the norm (by volume) for that product. The net effect of the data cleaning process is to further bias these figures downwards, as excessively large consignments were checked and corrected when errors were found, but low figures were not. As well as similar tests for errors, the data for 1699-1774 was all manually re-checked against the original Ledgers. The selection process is inherently subjective -in particular, scents and preservatives overlapped in this period -but the trends described below are robust to changes in the content of the medical drug sample. These practical and methodological challenges mean that the data presented should be seen as a set of rough estimates, proxies for a set of real changes that we cannot now fully recover. Although values are discussed for convenience, it is the rates of change that are most reliable.
The problems are particularly obvious for the aggregate data on drugs as a category, but even the figures for individual drugs presented in Appendix C need to be treated with care.
29 Although notionally actual prices, the Customs' ad valorum estimations quickly became fixed. 1722-74 was a time of relatively little change in official prices (unlike 1699-1701) and therefore gave a large sample from which to work, despite their greater chronological distance from the 1660 rate book : Clark 1938; Davis 1962, p. 285. 30 In 1699-1701, they would contribute 3.8% to a series based on medical drugs with values in the 1660 and 1725 Rate Books. For 1722-24, 1752-54, and 1772-74, the equivalent figures are 2.6%, 2.4%, 2.5%. 31 See Appendix B for a full list of drugs imported.
Drug Imports
Between the late sixteenth and the late eighteenth centuries, English drug imports increased substantially. Annual totals for imports are given in table 1. Both imports of commodities classified as 'drugs' in the rate books and the narrower sample of 'medical drugs' increased massively between 1567 and 1774, rising by around two orders of magnitude. By the 1770s, medical drug imports were running at around £100,000 a year, fifty times greater than the £1,000 to £2,000 a year common two centuries earlier. Drug imports grew much more rapidly over this period than imports in general, which increased by roughly twelve times.
[Insert table 1 near here]
The growth in medical drug imports was concentrated in the seventeenth century. In the second half of the sixteenth century, the quantity of drugs imported was small and relatively stable. In the years for which we have data, 1567, 1588-89, and 1600, the value of imports of medical drugs ranged around one and two thousand pounds a year.
There was no obvious trend of growth or decline in the volume of trade in this period, as was the case for English imports in general.
Signs of growth are visible in 1609, and from the 1620s to the 1660s drug imports increased substantially. In 1629, the peak year in our sample before the 1680s, the volume of imports was £25,774, over ten times greater than the average for the late sixteenth century. The figures for 1617-24, 1633 and 1638 suggest a slightly more modest level of imports was normal, but even they were consistently five times higher than the earlier norm. Such annual variations are unsurprising for trade.
The data for the 1660s, although based on summary figures, suggest that 32 Imports were c. £1 million in 1600, and £13 million in 1772-74: Davis 1962, p.300. trade in drugs had expanded further. Imports in 1662-8 were higher than had been normal in the 1620s and 1630s (although not dissimilar to 1629). In the later seventeenth century there was a further substantial increase in the volume of medical drugs imported. Although by no means smooth, the rate of growth was high across the seventeenth century as a whole. The level of imports in 1699-1701 was 27 times higher than a century earlier.
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Over the eighteenth century, the volume of medical drugs imported grew much more slowly. Imports actually fell between 1700 and 1723.
They rose again by the 1750s, before apparently stagnating at around twice the level at the start of the century. Even with three year averages, this oscillation is not surprising given the effect that relatively small volumes of highly priced drugs could have on the totals. Over the century, the growth in medical drugs was much lower than the 217 per cent increase in the level of English imports in general. 34 Imports of the wider customs category of 'Rate Book Drugs' grew at roughly the same rate, with an expansion in the importation of black lead, borax, sandalwood, and turpentine in particular. In 1772-74, these non-medical 'drugs' made up four of the five 'drugs' imported in largest quantities. Rhubarb was the only 'medical' drug among the five most significant drug imports by value, at fifth place.
[insert is probably an over-estimate. Nonetheless, it seems reasonable to conclude that the rate of growth in English drug consumption in these decades may have been even higher than suggested by the import data alone.
From 1640 to 1699 no useful information about re-exports survives.
From 1699 onwards, however, the Customs records include extensive data on both exports and re-exports. These remain high. As can be seen in table 3, around half of drug imports were re-exported. However, as the total size of the drug trade had grown substantially, the volume of medical drugs retained for consumption was now much larger. By the start of the eighteenth century, domestic consumption was more than twice the level in the 1630s. Tellingly, given that retained imports around 1600 could not exceed the total of imports, these figures imply that by 1700 the level of English medical drug consumption was at least fifteen times higher than a century earlier.
After 1700, medical drug consumption followed a very different Davis 1962, p. 302. some point in the period. 44 In addition to these figures for the number of types of drugs imported in reasonable bulk, we must allow for the importation of smaller quantities of drugs that were not listed individually.
The diversity of the early modern published pharmacopoeias was, it seems, reflected in the variety of drugs available.
While consumers' demand for a wide range of medicinal substances was met to some degree, a much smaller group of drugs made up the majority of imports. While this evidence of dosages imported indicates the appearance of a mass market for medicines, the ability of the sick to utilize different medical treatments, and the impact of their decision to consume, is a function of price as well as availability. Evidence on the prices of drugs is even scarcer than evidence on levels of imports. However, for the 1660s to the 1730s and for a few years in the 1790s some bulk wholesale prices for drugs sold in the London market are available from surviving Price Courants, essentially price newspapers for merchants. 48 Prices for nine prominent drugs are presented in table 6. The prices have been deflated using Allen's Consumer Price Index for London, which contains a basket of food based on a labourers' diet, with 1666-75 taken as the base year.
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Inflation has little effect until the 1790s.
Despite capturing the last period of rapid expansion in drug imports in the later seventeenth century, there is no clear trend in drug prices between the 1660s and 1700. The prices of Benjamin, Senna, Opium, Scammony were remarkably stable. Wormseed and rhubarb increased in price, the latter by more than 100 percent. The prices of Aloes Socotrina and Sarsaparilla did both fall by roughly a third, but Jesuits Bark was the only drug to see a very large fall in price (although its initial high price is 48 Price 1954, pp. 240-9. 49 Allen 2001.
based on a single price report) of the kind that might be expected when the quantity imported grows so quickly. By the end of the eighteenth century, the real price had fallen for five drugs: Aloes Socotrina, Benjamin, Jesuits Bark, Opium, Sarsaparilla. However, Rhubarb and Senna cost around the same as in the 1660s, while Scammony was twice as expensive and Wormseed was no longer listed. An un-weighted average of the relative change of the drug prices in table 6 suggests that prices in the 1790s were on average 15 percent lower than in the 1660s:
a small change when medical drug imports were ten times higher.
Unfortunately, the Price Courant price data only begins after the most dramatic growth in drug imports had ended. Figures from earlier in the century suggest that prices for some drugs may have fallen significantly by the 1660s. In the early 1630s, the wholesale price for Senna (42d/lb), rhubarb (253d/lb), Benjamin (80d/lb), Opium (160d/lb) and Sarsaparilla (80d/lb) were all markedly higher than later in the century. 50 For these five drugs, prices fell on average by around 50 percent between the 1630s and 1660s. As these are wholesale druggists' prices, not port prices, they may overstate the decline, but it seems likely that the initial expansion in drug imports was accompanied by substantial price falls.
Conclusion
Taken together, the shifts in price and imports show the key characteristics of the evolution of the English medical drug trade over this period. In particular, the seventeenth century seems to have been the period of greatest expansion in supply. While drug prices fell initially, it seems that the demand for medicines outstripped supply over the last half given the range of industrial uses of their raw materials, the ongoing popularity of Galenic simples provides little evidence of a change in the content of medicine that might be responsible for shifts in consumption.
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More significantly, the increasing supply of drugs suggests that much of the increase in expenditure in Probate Accounts may have been due to purchases of medicines rather than services. 56 Economies of scale are easier to achieve in pharmacy than direct medical or surgical assistance, allowing us to assume more moderate increases in the workload of medical practitioners.
53 Wallis 2002 , pp. 217-21. 54 Mortimer 2009 , pp. 204-5. 55 Mortimer 2009 Probate Accounts are too terse for this distinction to be made in most cases, and as Mortimer emphasizes the provision of 'physic' was the most common service : Mortimer 2009, p.73. The kinds of medical drugs imported also changed over this period.
However, the changes were mainly an expansion in the pharmacopoeia, 
